DiGeorge/velocardiofacial syndrome (DGS/VCFS) is a disorder caused by a 22q11.2 deletion mediated by non-allelic homologous recombination (NAHR) between low-copy repeats (LCRs). We have evaluated the role of LCR22 genomic architecture and PRDM9 variants as DGS/VCFS predisposing factors. We applied FISH using fosmid probes on chromatin fibers to analyze the number of tandem repeat blocks in LCR22 in two DGS/VCFS fathers-of-origin with proven 22q11.2 NAHR susceptibility. Results revealed copy number variations (CNVs) of L9 and K3 fosmids in these individuals compared to controls. The total number of L9 and K3 copies was also characterized using droplet digital PCR (ddPCR). Although we were unable to confirm variations, we detected an additional L9 amplicon corresponding to a pseudogene. Moreover, none of the eight DGS/VCFS parents-of-origin was heterozygote for the inv(22)(q11.2) haplotype. PRDM9 sequencing showed equivalent allelic distributions between DGS/VCFS parents-of-origin and controls, although a new PRDM9 allele (L50) was identified in one case. Our results support the hypothesis that LCR22s variations influences 22q11.2 NAHR events, however further studies are needed to confirm this association and clarify the contribution of pseudogenes and rare PDRM9 alleles to NAHR susceptibility.
The human genome is constituted by 5% of segmental duplications (SDs) or low-copy repeats (LCRs). They are defined as near-identical DNA segments (>90% sequence identity), longer than 1 kb and repeated in tandem or interspersed throughout the genome1. LCRs contain genes, pseudogenes, repetitive elements and recombination motifs2,3, which render LCRs unstable and make them prone to misalignments that can lead to non-allelic homologous recombination (NAHR). NAHR events occurring during meiosis result in chromosome reorganizations that can be transmitted to the offspring4,5,6. This process played an important role during primate evolution, which has been deduced from the significant SD expansion in the human genome7. NAHR events mediated by LCRs are also responsible for the copy number variations (CNVs) that introduce genetic diversity between individuals8. However, some CNVs also originate a group of diseases that have been referred as genomic disorders9.
NAHR activity during meiosis can be evaluated in gametes by estimating the rearrangement frequency at a specific locus with polymerase chain reaction (PCR)10 or fluorescence in situ hybridization (FISH)11. Sperm-FISH studies in Prader-Willi syndrome (PWS) and DiGeorge/velocardiofacial syndrome (DGS/VCFS) fathers-of-origin have demonstrated that there are individuals with an increased susceptibility to deletions12,13. The recurrence risk for PWS and DGS/VCFS in these individuals is considered higher than the general population due to their increased susceptibility to NAHR events during spermatogenesis.
NAHR susceptibility in parents-of-origin has been related to different genetic features. CNVs in the LCRs flanking the critical regions have been described as predisposing factors for Smith-Magenis and Potocki-Lupski syndrome14,15, Williams-Beuren syndrome16 and 16p12.1 microdeletion disease17. Inversions of the critical region have been related to the occurrence of Prader-Willi/Angelman syndromes18,19, Williams-Beuren syndrome20,21,22, Smith-Magenis syndrome23, 17q21.31 microdeletions24 and t(8;22)25, among other genomic disorders26. According to these observations, genomic architecture variations in parents-of-origin may confer a higher likelihood of LCR misalignment during meiosis and consequently a higher susceptibility to NAHR events. Moreover, variants of recombination genes have also been associated with altered frequency and stability of meiotic recombination that might also predispose to NAHR27,28. The PRDM9 protein regulates the pattern of meiotic recombination in the mammal genome by recruiting the double-strand break machinery after recognizing consensus sequences constituted by zinc finger domains29,30. Nucleotide changes in zinc finger domain shift the binding motif and modify the hot-spot pattern31. Therefore, the PRDM9 genotype determines the likelihood of a NAHR event in a critical region. In this context, some PRDM9 alleles have been suggested to increase the risk for transmitting Charcot-Marie-Tooth type 1 A, hereditary neuropathy with liability to pressure palsies and Williams-Beuren syndrome, among other genomic disorders28,32,33.
The DiGeorge/velocardiofacial syndrome (DGS/VCFS) (OMIM 188400/OMIM 192430) is the most common deletion syndrome in humans, with an incidence of 1:4000 newborns34. The genetic cause is gene haploinsufficiency resulting from a microdeletion of the 22q11.2 region. Roughly 11% of this region is comprised by eight highly homologous LCRs (LCR22-2, LCR22-3a, LCR22-3b, LCR22-4, LCR22-5, LCR22-6, LCR22-7 and LCR22-8)35. LCR22s act as substrate for the pathogenic rearrangements that originate DGS/VCFS, as well as a variety of other genomic disorders36. Focusing on DGS/VCFS rearrangements, they involve LCR22-2 and LCR22-4 in more than 85% of cases, giving rise to a 3 Mb deletion37. NAHR between LCR22-2 and LCR22-3a originates a 1.5 Mb deletion which affects 7% of cases. Distal LCR22s are involved in the remaining DGS/VCFS unusual deletions38,39,40 (Fig. 1A).
Little is known about the variability of the 22q11.2 genomic architecture and its influence in NAHR susceptibility41. Some authors have hypothesized about a possible relationship between the frequency of 22q11.2 rearrangements and variations in LCR22s13,42,43. On the other hand, although in other genomic disorders the presence of heterozygote inversions has been associated with an increased frequency of rearrangements, no inv(22)(q11.2) have been described in DGS/VCFS parents44,45. The influence of the PRDM9 genotype in the DGS/VCFS transmission risk has also been discussed; nevertheless, an association of PRDM9 allele and NAHR susceptibility has not been clearly established32,46.
In this work, we assessed if the risk of DGS/VCFS is influenced by the genomic architecture of LCR22s, the presence of 22q11.2 inversions and the PRDM9 genotype. First, we analysed CNVs of tandem sequence blocks within LCR22-2 and LCR22-4 and CNVs of paralogous sequences interspersed throughout LCR22s using FISH on extended chromatin fibers (fiber-FISH) and droplet digital PCR (ddPCR), respectively. Second, we developed an interphase FISH assay to genotype inversions between LCR22-2 and LCR22-4. Finally, we analysed the PRDM9 genotype by sequencing the zinc finger array.
LCR22-2 and LCR22-4 tandem sequence blocks
The LCR22-2 and LCR22-4 genomic architecture was analysed in lymphocyte stretched chromatin fibers using fosmid and single-copy BAC clones (Human genome February 2009 assembly; UCSC Genome Browser; http://genome.ucsc.edu/) (Fig. 1B). Single copy BAC clones were selected to delimit the proximal and distal ends of LCR22-2 (RP11-66F9 (abbr. F9) and RP11-163A10 (abbr. A10)) and LCR22-4 (RP11-505B16 (abbr. B16) and RP11-47L18 (abbr. L18)). The experimental design also required the use of fosmid clones covering the length of LCR22-2 (WI2-938L9 (abbr. L9), WI2-451K3 (abbr. K3), WI2-1268B22 (abbr. B22) and WI2-1822L21 (abbr. L21)) and LCR22-4 (WI2-938L9 (abbr. L9), WI2-451K3 (abbr. K3), WI2-1268B22 (abbr. B22), WI2-2886M12 (abbr. M12) and WI2-3344I18 (abbr. I18)) (Fig. 1B and Supplementary Table S1).
Normal ranges of tandem sequence blocks were established by taking the smallest and the largest CNVs observed within six control individuals. For LCR22-2, normal ranges were 2–6 copies for L9, 3–9 copies for K3, 1–4 copies for B22 and 1–2 copies for L21; for LCR22-4 were 1–2 copies for L9, 1–3 copies for K3, 1–2 copies for B22, 2–2 copies for M12 and 2–3 copies for I18 (Table 1; Fig. 2). Two DGS/VCFS fathers-of-origin with a previously proven 22q11.2 NAHR susceptibility were also examined13. Both fathers showed out of range numbers of fosmid blocks. DG2F presented two copies of K3 blocks in both LCR22-2 haplotypes rather than the 3–9 copies in the controls, and three copies of L9 blocks in one LCR22-4 haplotype rather than the 1–2 copies in controls. Otherwise, DG5F presented eight copies of L9 blocks in both haplotypes from LCR22-2 rather than the 2–6 copies in the controls, and three copies of L9 blocks in one haplotype from LCR22-4 rather than the 1-2 copies in controls (Table 1; Fig. 2).
LCR22 paralogous sequences
To validate the fiber-FISH results, the total number of L9 and K3 blocks scattered around LCR22s was analysed by ddPCR using lymphocyte genomic DNA. This was done in those samples previously analysed by fiber-FISH (C1, C2, C3, C4, C5, C6, DG2F and DG5F). The L9 and K3 ddPCR results did not correlate with fiber-FISH (Spearman correlation test, r = 0.156 and 0.386, P = 0.703 and 0.360, respectively).
Next, we determined the normal range of L9 and K3 copies in 21 and 6 control samples respectively. The L9 range extends from 12.7 to 29.6 (Fig. 3A), while K3 extends from 10.6 to 21 (Fig. 3C). The mean L9 copy number in controls and in the eight DGS/VCFS parents-of-origin was 19.54 and 21.28 respectively, while the mean K3 copy number was 15.33 in controls and 17.46 in DGS/VCFS parents-of-origin. However, L9 and K3 copies failed to reach significant differences between both groups (Mann Whitney test, P = 0.420 and 0.477, respectively). At the individual level, only DG1F obtained a K3 copy number above the normal range observed in controls (22 copies) (Fig. 3A).
Interestingly, we detected two types of amplicons for L9 fosmid which were differentiated by the fluorescence amplitude (Fig. 3B). It has been described that droplets with lower fluorescence amplitude are amplicons of different size that may correspond to pseudogene sequences47. 66.67% of control individuals (14 of 21) presented two or more copies per genome of the L9 pseudogene, while in DGS/VCFS parents-of-origin this figure reached only 37.50% (3 of 8) (Fig. 3A). However, these differences did not reach statistical significance (Fisher exact test, P = 0.218).
22q11.2 inversions were evaluated in five control individuals and eight parents-of-origin. We performed an assay using a combination of three BAC clones including RP11-66F9 (abbr. F9) covering the proximal end of the LCR22-2 and RP11-505B16 (abbr. B16) and RP11-47L18 (abbr. L18) covering the proximal and the distal end of the LCR22-4, respectively (Fig. 1C and Supplementary Table S1).
A total of 1354 informative signal combinations, 512 from control individuals and 842 from DGS/VCFS parents-of-origin, were analysed (Supplementary Table S2). The mean frequency of normal haplotypes was 96.08% in control individuals (range 94.12% to 98.06%) and 96.92% in DGS/VCFS parents-of-origin (range 94.55% to 99.02%). The mean frequency of the 3 Mb inversion haplotype was 1.57% in control individuals (range 0.96% to 2.94%) and 1.56% in DGS/VCFS parents-of-origin (range 0% to 2.91%). We also detected a negligible percentage of informative haplotypes with an unexpected probe association attributed to inherent hybridization errors (Supplementary Table S2).
The frequency of 3 Mb inversions was statistically significant lower than the frequency expected in a heterozygous situation in all the cases (Chi square-test, P < 0.05) (Table 2 and Supplementary Table S2). Haplotype frequencies were not different between both populations (Mann Whitney test, P > 0.05).
Sequencing of the PRDM9 zinc finger array was performed in 19 control individuals and eight DGS/VCFS parents-of-origin. We observed the common A allele, constituted by 13 zinc finger repeats (ZF), in 86.84% of our control population and in 81.25% of the case population. One new allele showing more than 13 ZF was identified (L50); unfortunately, we were unable to define its ZF combination due to technical limitations (Fig. 4 and Supplementary Table S3).
Control and case allele frequencies did not show differences (Fisher’s exact test, P > 0.05). DGS/VCFS fathers showing an increased NAHR susceptibility at 22q11.2 (DG2F and DG5F) presented the A/L50 and A/A genotypes, respectively.
The recurrence risk for transmitting genomic disorders is generally considered not higher than that for the normal population. However, some insights have been provided into the predisposing genetic factors for these diseases. Our exploratory analyses reveal that the LCR22 genomic architecture, through CNVs of the segmental duplication blocks, could be a predisposing factor for transmitting DGS/VCFS.
LCR sequences present a poor precision within databases, which complicates the knowledge of their structural variation. Their repetitive nature constitutes an important impediment for accurate sequencing procedures. Nonetheless, different approaches, such as massively parallel sequencing techniques, PCR or FISH, have been applied to analyse repetitive regions16,48,49,50,51. Fiber-FISH provides a direct analysis of genome architecture with high resolution, i.e. 10–20 kb52. Moreover, the visualization of repeating patterns allows for identifying heterozygote haplotypes and analyzing LCRs individually. For these reasons, fiber-FISH is the preferred method for studies of the genomic structure of complex CNVs53. However, it cannot differentiate tandem copies of the regions recognized by the fosmids. Accordingly, we had to consider that, in the visualization of repeated patterns, each signal corresponds to a block of tandem sequences of each fosmid (Fig. 1C). Despite overtaking the identification of tandem sequences and detecting pseudogene sequences, PCR-based methods cannot differentiate heterozygote haplotypes or analyse variations at the LCR level.
CNVs within LCRs have been previously reported in a database of genomic variants, thus demonstrating their polymorphic length54. Our ddPCR results reinforce this interpretation since the data show the inter-individual variability of LCR22 repeated sequences. Moreover, the fiber-FISH results show that LCR22-2 inter-individual variability was higher than that of LCR22-4. Focusing on those fosmid clones analysed in both LCRs (L9, K3 and B22), LCR22-2 showed larger ranges of tandem sequence blocks per fosmid, especially from those blocks corresponding to tandem sequences of L9 and K3. On the contrary, LCR22-4 showed less variable numbers for the five fosmids analysed with restricted ranges of copies and minor differences between individuals (Fig. 3, Table 1). These observations suggest that LCR22-2 is longer than LCR22-4. Indeed, LCR22-2 mediates the majority of rearrangements affecting the 22q11.2 region and is the LCR22 with the highest rates of allelic homologous recombination (AHR)43. Probably a longer LCR22 might contain more recombination motifs, which what would explain its higher AHR and also the increased likelihood of misalignments and NAHR events. Concordantly, LCR length, homology degree of segmental duplication blocks and the density of recombination motifs have been related to the NAHR frequency of recurrent rearrangements3.
In DGS/VCFS fathers-of-origin, we identified abnormal CNVs of the tandem sequence blocks for L9 and K3 fosmids. We previously demonstrated that these individuals showed significant increases of sperm 22q11.2 deletions13. In both cases, the deletion in the affected children correspond to the 3 Mb segment between LCR22-2 and LCR22-413. Furthermore, parallel investigations in the same individuals determined the rearrangement frequency at other critical regions with a similar genomic architecture by applying sperm FISH experiments based on the methodology described by Molina et al.11. These studies demonstrated that NAHR susceptibility was restricted at the DGS/VCFS critical region because they presented normal deletion and duplication sperm rates for the Williams-Beuren syndrome and the Prader-Willi syndrome regions (7q11.23 and 15q11-q13) (Table 2; unpublished data). Altogether, our results support the association between increased rates of rearrangements during spermatogenesis and specific genetic features of the critical region and reject a generalized instability origin for these abnormal deletion rates.
CNVs within LCRs affect the number of different types of sequences such as genes, pseudogenes and recombination motifs. The L9 and K3 sequences (UCSC Genome Browser) encompass partial or complete genes and pseudogenes; L9 covers USP18 and AK129567, whereas K3 covers AK302545 and GGT3P. The density of PRDM9 A binding motifs (CCNCCNTNNCCNC) is three on L9 and two on K3. It is important to remark that the gene AK129567 covered by L9 sequence belongs to the common breakpoint region of the 22q11.2 deletion55. The most frequent breakpoints at LCR22-2 and LCR22-4 occur in regions including DGCR6, PRODH and AK129567 at the proximal end and GGT2, HIC2, RIMBP3 and AK129567 at the distal end55. These regions are also covered by the fosmid sequences L21 and M12 which, despite presenting a low variation in our analyses, contain higher sequences of recombination motifs (eight and 14, respectively) (Supplementary Table S4). It has been demonstrated that the PRDM9 recombination motif density at LCRs has a positive correlation with the NAHR frequency. Specifically, structural variants generated by NAHR present breakpoints enriched with PRDM9 defined hotspots3,28,29. Hence, the concentration of PRDM9 recombination motifs may define the location of the rearrangement breakpoints, whereas the misalignment probability could be driven by variations in the degree of homology between paralogous sequences. L9 and K3 CNVs might produce variations in the degree of homology between LCR22-2 and LCR22-4, leading to non-allelic alignments of the susceptible breakpoint regions during meiotic prophase I that would be solved in NAHR events. Instead, the DSB formation to start a NAHR event might be driven by adjacent sequences with a high recombination motif density, such as L21 or M12 sequences.
Different authors have reported a correlation between the alignment length and the sequence identity between paired LCRs and NAHR frequency3,56, thus supporting the idea that CNVs at LCRs might change NAHR susceptibility. Moreover, according to the ectopic synapsis model15, variations in the length of the LCRs might originate ectopic presynaptic contacts between near homologous segments that would act as a precursor to NAHR.
Regarding the total number of paralogous LCR22s sequences, the ample spectrum of CNVs detected endorse the polymorphic variation of these sequences and the uncertainty of the human reference assemblies in LCR regions. Comparing the control and DGS/VCFS parent-of-origin populations, we did not find any relationship between the CNVs of paralogous sequences and the risk for transmitting DGS/VCFS. At the individual level, we observed one DGS/VCFS father-of-origin with a CNV of K3 sequences out of the control range. However, considering that this father did not show NAHR susceptibility in previous studies13 and that, due to the technical characteristics of ddPCR, we could not attribute the higher copy number to a specific LCR22, we believe that this outcome is not relevant for the evaluation of the transmitting risk of this subject. Analyses of CNVs in multiple LCRs using ddPCR concealed variations in specific LCRs detected by fiber-FISH. This situation explains the lack of concordance between the data provided by both techniques and reinforces the need to analyse the LCR architecture with LCR-specific methods.
Although the CNVs of pseudogene sequences were not conclusive due the limited sample size, we do believe that the presence of such sequences could be another variable to take into account. Genetic variations in pseudogene sequences located at LCRs have been already proposed as rearrangement promoters57. We observed that, in DGS/VCFS parents-of-origin, the presence of a possible AK129567 pseudogene sequence was less frequent than in the general population. The absence of pseudogene sequences might alter the degree of homology between LCR22-2 and LCR22-4, enhancing their misalignment, which would cause more NAHR events. Nevertheless, as we have just described, the ddPCR technique hampers the assignation of these CNVs to any LCR22. Consequently, we are aware that these pseudogene sequence variations might be located in a LCR that is not involved in the DGS/VCFS reorganization.
Parental inversion polymorphisms have also been proposed as a susceptibility factor for NAHR events in multiple genomic disorders, especially in Williams-Beuren syndrome20,21,22. With regard to the 22q11.2 inversions, in agreement with the work of Gebhardt et al.44 and Saitta et al.45, we did not observe any haplotype corresponding to the 3 Mb inversion, either in DGS/VCFS parents-of-origin or in control individuals. These results discard the presence of heterozygous inversions as a predisposing factor for 22q11.2 deletions.
Concerning the role of the PRDM9 genotype, we did not find differences between the allelic frequencies of controls and DGS/VCFS parent-of-origin populations. Despite the limited sample size, and considering that other authors also failed to identify this association32,46, the results indicate that there are non-specific PRDM9 alleles related to DGS/VCFS susceptibility. Accordingly, our data support the idea that the PRDM9 genotype has a limited influence on NAHR events. Indeed, although the PRDM9 A allele has been proposed as a predisposing factor for CMT1A or HNPP33, this allele is extremely common in Caucasians, suggesting that this genetic feature cannot be a predisposing factor by itself33. However, it is interesting to note that the finding of a minor and undescribed allele in DG2F might indicate a possible influence as a NAHR catalyst in this individual. Actually, rare PRDM9 alleles might contribute to different hotspot patterns that create unusual DSBs at disease-causing 22q11.2 deletion breakpoints.
The risk of transmitting a genomic disorder is a complex trait that could be attributed to a confluence of different genetic characteristics. First, regarding the 22q11.2 genomic architecture, we have raised the possibility that CNVs of segmental duplication blocks within LCR22-2 and LCR22-4 could be considered as a DGS/VCFS predisposing factor. Moreover, our results also suggest a possible implication of pseudogene sequence CNVs. Second, although the PRDM9 genotype does not seem to be a decisive predisposing factor, we cannot reject its contribution in the definition of the DGS/VCFS transmitting risk due to the possible existence of rare PRDM9 alleles capable of creating new hot spot patterns. The PRDM9 genotype and the LCR22 genomic architecture could have a synergistic effect considering that CNVs at LCR22s also vary the number and distribution of recombination motifs.
Our results provided a comprehensive approximation to the analysis of DGS/VCFS predisposing genetic factors in parents-of origin. Although designed as an exploratory study, results suggested that CNVs in LCR22s predispose to sperm 22q11.2 deletions. Nevertheless, further studies is a larger cohort of individuals are needed to confirm the contribution of segmental duplication blocks, and better understand the participation of pseudogenes and rare PDRM9 alleles to NAHR 22q11.2 susceptibility.
This study was carried out on six DGS/VCFS fathers-of-origin, two DGS/VCFS mothers-of-origin and a total of 26 control individuals (Fig. 5). To our knowledge, none of them had been exposed to genotoxic agents, and no history of chemotherapy, radiotherapy or chronic illness was recorded. In DGS/VCFS families, the parental origin of the deleted chromosome, and the frequency of sperm 22q11.2 deletions, were previously reported13.
All the individuals gave their informed consent in writing to participate in the study and the protocols were approved by the Ethics Commission on Human and Animal Experimentation of the Universitat Autònoma de Barcelona. All experiments were conducted in accordance with the informed consent and the approved guidelines.
Peripheral blood samples were collected in EDTA-containing tubes (5 ml). Genomic DNA was isolated using the Gentra Puregene Blood kit (QUIAGEN Inc.) following the manufacturer’s instructions. Peripheral blood samples were also collected in 1% sodium heparin tubes in eight DGS/VCFS parents-of origin and ten control individuals (10 ml) (Supplementary Table S4 and Fig. 5).
LCR22-2 and LCR22-4 tandem sequence blocks
Chromatin fibers were obtained according to a previously described protocol58. Lymphocytes were isolated from peripheral blood samples in 1% sodium heparin by Ficoll-PaqueTM gradient separation. The lymphocyte phase was centrifuged and the pellet was washed in 1x PBS. The lymphocyte pellet was resuspended in 1x PBS to reach a final concentration of 2.106 cells/ml. 10 μl of the lymphocyte isolation was spread and dried on slides. Slides were placed in Shandon Sequenza Coverplates and chromatin fibers were stretched by applying a lysis solution (0.07 M NaOH in ethanol). Fibers were fixed in methanol and stored at −20 °C until they were processed.
DNA probe preparation
BAC and fosmid clones were provided by BACPAC Resources Center, CHORI, USA (http://bacpac.chori.org/) and Source BioScience (Supplementary Table S1). We validated probe positioning and efficiency using FISH on metaphase chromosomes (see Methods, 22q11.2 inversions).
FISH probes were purified from BACs and fosmid clones using the QIAprep Spin Miniprep Kit (QIAGEN) and differentially labelled with Spectrum Orange-dUTP (Abbot Molecular) or digoxigenin-11-dUTP (Roche) by Nick Translation (Abbot Molecular). Multiple colour combinations of two delimiting BAC clones and one fosmid were simultaneously hybridized on DNA fiber slides. The proximal BAC was labelled with both Spectrum Orange and digoxigenin-FITC, the fosmid with digoxigenin-FITC and the distal BAC with Spectrum Orange (Fig. 1B).
After the NICK translation reaction, probes were ethanol precipitated with 1 μg/ml salmon testis DNA (GE Healthcare) and 3 M sodium acetate (pH 5.5) at −80 °C for 3 h. Probes were purified by centrifugation at 14,000 rpm for 30 minutes, followed by a wash in 70% ethanol and centrifugation at 14,000 rpm for 6 minutes. The probe pellet was air-dried, resuspended in 1x TE buffer (10 mM Tris, 1 mM EDTA, pH 7.0) at a concentration of 20 ng/μl and stored at −20 °C.
FISH on extended chromatin fibers (Fiber-FISH)
Probe combinations were prepared by mixing 400 ng of each labelled DNA probe with 8 μg of Cot1 competitor DNA (Invitrogen) per probe. The probe hybridization mixture was dried on a heating block at 42 °C and the pellet was resuspended in 10 μl of LSI/WCP Hybridization Buffer (Abbot Molecular). Before hybridization, probes were denatured at 75 °C for 5 minutes and pre-annealed at 37 °C for 45 minutes.
Slides were dehydrated in an ethanol series (70, 90 and 100% for 2 minutes each) and dried at room temperature. Chromatin fibers were denatured in 70% formamide/2x SSC at 70 °C for 2 minutes, washed in 2x SSC for 5 minutes and dehydrated in an ethanol series (70, 85 and 100% for 1 minute each). Probes were applied to slides and hybridized in a moist chamber at 37 °C for 48 hours.
Post-hybridization washes were performed in 2x SSC at 42 °C for 3 minutes, followed by 1x PBS at room temperature for 5 minutes. Slides were incubated in a blocking solution (5% dried non-fat milk in 1x PBS/0.05% Tween-20 (Sigma-Aldrich)) at 37 °C for 30 minutes. Then slides were transferred to 1x PBS at room temperature for 5 minutes, followed by one hour incubation at 37 °C in detection solution (1% dried non-fat milk in 1x PBS/0.05% Tween-20 (Sigma-Aldrich) with 1 μg/ml fluorescein-conjugated antidigoxigenin (Roche)). Finally, slides were washed three times in 1x PBS for one minute, dried out at room temperature and counterstained with 4’,6-diamidino-2-phenylindole (DAPI, Vysis).
Image acquisition and data analyses
A minimum of 20 informative fibers were scored for every single probe combination on an Olympus BX60 epifluorescence microscope equipped with Isis Imaging System (Metasystems). Fiber-FISH analyses were developed by applying the following assessment criteria adapted from Molina et al.50: (i) at least three signals of different colour combinations must be observed in a consecutive and linear fashion, ii) two or more signals of the same colour are considered independent when they are separated by a distance twice the distance of every single bead-on-string, and iii) signals are considered informative regardless of the size (Fig. 1D). For each BAC and fosmid combination, we scored the frequency of the fosmid signal numbers that corresponded to the tandem sequence blocks.
LCR22 paralogous sequences
ddPCR was performed using genomic DNA isolated from peripheral blood samples in EDTA. To achieve an optimal fragmentation of LCR22 tandem sequences, 2 μg of genomic DNA was digested with 20U of HaeIII (New England Biolabs) in a final volume of 25 μl containing 1x NEB4 buffer for 1 h at 37 °C. The digest was diluted to a final concentration of 6 ng/μl and 9 ng were assayed per 20 μl ddPCR reaction. Primers and probes were designed for L9 and K3 fosmid clones (reported abnormal CNVs of tandem sequence blocks in DGS/VCFS fathers-of-origin). L9 fosmid sequences were assayed using forward primer CAGTGGGACTCTCATCAAAC, reverse primer AGGAGCGAGAAATAGAGTCC and probe FAM-AAAGTTGCCATCAGCCAGATGCCAG-Iowa Black®FQ. The 116 bp amplicon corresponded to AK129567 gene. K3 fosmid sequences were assayed using forward primer ATTTTGCGGTGTCAGAAGGT, reverse primer CCTCTCAGTGACTGTCTCCT and probe FAM-CGGGAGGCAAGCAGTCCCTGGTCC-Iowa Black®FQ. The 92 bp amplicon corresponded to AK302545 gene. Both assays were duplexed with an EIF2C1 reference assay probe labelled with HEX/Iowa Black®FQ (PrimePCR™ ddPCR™ Copy Number Assay EIF2C1, Bio-Rad). Amplification conditions were 95 °C for 10 min (1 cycle), 94 °C for 30 s and 55.5 °C × 60 s (40 cycles), 98 °C × 10 min (1 cycle), and 4 °C hold. Each assay was performed in two replicate ddPCR wells. After PCR, the 96-well PCR plate was loaded on the droplet reader (Bio-Rad). Positive and negative droplet counts were analysed combining data from both replicates and using QuantaSoft analysis software (Bio-Rad). For each replicate, we obtained an average number of the amplified copies from two haplotypes.
Lymphocytes from peripheral blood samples (collected in 1% sodium heparin) were cultured in phytohaemagglutinin-stimulated medium at 37 °C in a 5% CO2 atmosphere for 72 h. Cells were treated with colcemid, swelled after a hypotonic treatment (75 mM KCl) and fixed with 3:1 methanol-acetic acid.
DNA probe preparation
A customized combination of BAC clones RP11-66F9 (abbr. F9), RP11-505B16 (abbr. B16) and RP11-47L18 (abbr. L18) was used. Probes were labelled with Aqua-dUTPs (Abbott Molecular), Spectrum Green-dUTPs (Abbott Molecular) and Spectrum Orange-dUTPs (Abbott Molecular), respectively, as described previously for the fiber-FISH assays.
Probe combinations were prepared by mixing 200 ng of each labelled DNA probe with 4 μg of Cot1 competitor DNA (Invitrogen) per probe. The probe hybridization mixture was dried on a heating block at 42 °C and the pellet was resuspended in 5 μl of LSI/WCP Hybridization Buffer (Abbot Molecular).
Slides were washed twice in 2x SSC for 3 minutes, dehydrated in an ethanol series (70, 90 and 100% for 2 minutes each) and dried at room temperature. Slides were denatured in 70% formamide/2x SSC at 73 °C for 2 minutes, and dehydrated in an ethanol series (70, 85 and 100% for 1 minute each). Probes were applied to slides and hybridized in a moist chamber at 37 °C for 24 hours. Post-hybridization washes were performed in 1x SSC with 0.3% NP-40 at 73 °C and in 2x SSC with 0.1% NP-40 at room temperature for one minute in each solution.
Image acquisition and data analyses
Analyses were performed using an Olympus BX60 epifluorescence microscope equipped with an Isis Imaging System (Metasystems). Only those signal combinations with a clear distribution of two clustered signals (in close proximity or overlapping) and one separated signal were considered informative. The distant signal must be separated from the two others by at least a two-fold longer distance compared with the separation of the clustered signals. This probe configuration allowed us to distinguish the normal haplotype (N) and the 3 Mb inversion haplotype (inv) (Fig. 1C and E). A minimum of 100 informative signal combinations were analysed per sample. Metaphase chromosomes were also observed to test probe specificity.
The PRDM9 zinc finger array was amplified by PCR in genomic DNA isolated from peripheral blood samples in EDTA. PCR was performed using PN0.6 F and PN2.5 R primers (PN0.6 F: TGAGGTTACCTAGTCTGGCA, PN2.5 R: ATAAGGGGTCAGCAGACTTC)33, 3% DMSO and BioTaq (Bioline). Amplifications were performed as follows: 95 °C for 3 min; 45 cycles of 95 °C for 30 s, 62 °C for 30 s and 72 °C for 105 s. PCR products were purified with PCR DNA purification kit (Thermo Scientific) and subjected to bidirectional Sanger sequencing with the primers PN1.2 F and PN2.4 R (PN1.2 F: TGAATCCAGGGAACACAGGC and PN2.4 R: GCAAGTGTGTGGTGACCACA)33 using BigDye Terminator v3.1 Cycle Sequencing (Applied Biosystems) on a ABI 3130XL Genetic Analyzer (Applied Biosystems).
Data were statistically analysed using Graph Pad Prism 5.03. The statistical significance of the results was determined by a p-value less than 0.05.
Data from ddPCR replicates were averaged. To assess CNVs between LCR22 paralogous sequences from controls and DGS/VCFS fathers-of-origin, the mean copy number of each fosmid was compared between both populations using a Mann-Whitney test. In order to determine whether fiber-FISH and ddPCR technics were equivalent, the sum of the fosmid blocks of LCR22-2 and LCR22-4 per individual and the total copy number of LCR22 paralogous sequences were compared with a Spearman correlation test.
In the 22q11.2 inversion analyses, differences between haplotype frequencies from control and DGS/VCFS parent-of-origin populations were analysed by applying a Mann-Whitney test.
To ascertain the relevance of PRDM9 alleles in the risk for DGS/VCFS, the frequency of each allele was compared between controls and DGS/VCFS parents-of-origin with a Fisher exact test.
How to cite this article: Vergés, L. et al. An exploratory study of predisposing genetic factors for DiGeorge/velocardiofacial syndrome. Sci. Rep. 7, 40031; doi: 10.1038/srep40031 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Bailey, J. A. et al. Recent Segmental Duplications in the Human Genome. Science (80−). 297, 1003–1007 (2002).
Babcock, M. et al. Shuffling of Genes Within Low-Copy Repeats on 22q11 (LCR22) by Alu-Mediated Recombination Events During Evolution. Genome Res. 13, 2519–2532 (2003).
Dittwald, P. et al. NAHR-mediated copy-number variants in a clinical population: mechanistic insights into both genomic disorders and Mendelizing traits. Genome Res. 23, 1395–1409 (2013).
Ou, Z. et al. Observation and prediction of recurrent human translocations mediated by NAHR between nonhomologous chromosomes. Genome Res 2, 33–46 (2011).
Gu, W., Zhang, F. & Lupski, J. R. Mechanisms for human genomic rearrangements. Pathogenetics 1, 4 (2008).
Dittwald, P. et al. Inverted Low-Copy Repeats and Genome Instability–A Genome-Wide Analysis. Hum. Mutat. 34, 210–220 (2013).
Marques-Bonet, T., Girirajan, S. & Eichler, E. E. The origins and impact of primate segmental duplications. Trends Genet. 25, 443–454 (2009).
Sharp, A. J. et al. Segmental duplications and copy-number variation in the human genome. Am. J. Hum. Genet. 77, 78–88 (2005).
Stankiewicz, P. & Lupski, J. R. Genome architecture, rearrangements and genomic disorders. Trends Genet 18, 74–82 (2002).
Turner, D. J. et al. Germline rates of de novo meiotic deletions and duplications causing several genomic disorders. Nat. Genet. 40, 90–95 (2008).
Molina, O., Anton, E., Vidal, F. & Blanco, J. Sperm rates of 7q11.23, 15q11q13 and 22q11.2 deletions and duplications: a FISH approach. Hum Genet 129, 35–44 (2011).
Molina, O., Blanco, J. & Vidal, F. Deletions and duplications of the 15q11-q13 region in spermatozoa from Prader-Willi syndrome fathers. Mol Hum Reprod 16, 320–328 (2010).
Vergés, L., Molina, O., Geán, E., Vidal, F. & Blanco, J. Deletions and duplications of the 22q11.2 region in spermatozoa from DiGeorge/velocardiofacial fathers. Mol. Cytogenet. 7, 86 (2014).
Carvalho, C. M. B. & Lupski, J. R. Copy number variation at the breakpoint region of isochromosome 17q. Genome Res 18, 1724–1732 (2008).
Liu, P. et al. Frequency of nonallelic homologous recombination is correlated with length of homology: evidence that ectopic synapsis precedes ectopic crossing-over. Am. J. Hum. Genet. 89, 580–588 (2011).
Cuscó, I. et al. Copy number variation at the 7q11.23 segmental duplications is a susceptibility factor for the Williams-Beuren syndrome deletion. Genome Res 18, 683–694 (2008).
Antonacci, F. et al. A large and complex structural polymorphism at 16p12.1 underlies microdeletion disease risk. Nat Genet. 42, 745–750 (2010).
Gimelli, G. et al. Genomic inversions of human chromosome 15q11-q13 in mothers of Angelman syndrome patients with class II (BP2/3) deletions. Hum Mol Genet 12, 849–858 (2003).
Molina, O., Anton, E., Vidal, F. & Blanco, J. High rates of de novo 15q11q13 inversions in human spermatozoa. Mol Cytogenet 5, 11 (2012).
Osborne, L. R. et al. A 1.5 million–base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet. 29, 321–325 (2001).
Scherer, S. W. et al. Observation of a parental inversion variant in a rare Williams-Beuren syndrome family with two affected children. Hum Genet 117, 383–388 (2005).
Hobart, H. H. et al. Inversion of the Williams syndrome region is a common polymorphism found more frequently in parents of children with Williams syndrome. Am J Med Genet C Semin Med Genet 154C, 220–228 (2010).
Yang, S. P. et al. Molecular analysis of deletion (17)(p11.2p11.2) in a family segregating a 17p paracentric inversion: implications for carriers of paracentric inversions. Am J Hum Genet. 60, 1184–1193 (1997).
Rao, P., Li, W., Vissers, L. E. L. M., Veltman, J. & Ophoff, R. Recurrent inversion events at 17q21.31 microdeletion locus are linked to the MAPT H2 haplotype. Cytogenet Genome Res 129, 275–279 (2010).
Gotter, A. L. et al. A palindrome-driven complex rearrangement of 22q11.2 and 8q24.1 elucidated using novel technologies. Genome Res. 17, 470–481 (2007).
Antonacci, F. et al. Characterization of six human disease-associated inversion polymorphisms. Hum Mol Genet 18, 2555–2566 (2009).
Chowdhury, R., Bois, P. R. J., Feingold, E., Sherman, S. L. & Cheung, V. G. Genetic Analysis of Variation in Human Meiotic Recombination. PLoS Genet. 5, e1000648 (2009).
Pratto, F. et al. Recombination initiation maps of individual human genomes. Science (80−). 346, 1256442–1256442 (2014).
Myers, S., Freeman, C., Auton, A., Donnelly, P. & McVean, G. A common sequence motif associated with recombination hot spots and genome instability in humans. Nat. Genet. 40, 1124–1129 (2008).
Baudat, F., Imai, Y. & de Massy, B. Meiotic recombination in mammals: localization and regulation. Nat. Rev. Genet. 14, 794–806 (2013).
Baudat, F. et al. PRDM9 is a major determinant of meiotic recombination hotspots in humans and mice. Science 327, 836–840 (2010).
Borel, C. et al. Evaluation of PRDM9 variation as a risk factor for recurrent genomic disorders and chromosomal non-disjunction. Hum. Genet. 131, 1519–1524 (2012).
Berg, I. L. et al. PRDM9 variation strongly influences recombination hot-spot activity and meiotic instability in humans. Nat. Genet. 42, 859–863 (2010).
Devriendt, K., Fryns, J., Mortier, G., van Thienen, M. & Keymolen, K. The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 35, 789–790 (1998).
Babcock, M. et al. Hominoid lineage specific amplification of low-copy repeats on 22q11.2 (LCR22s) associated with velo-cardio-facial/digeorge syndrome. Hum. Mol. Genet. 16, 2560–2571 (2007).
McDermid, H. E. & Morrow, B. E. Genomic disorders on 22q11. Am. J. Hum. Genet. 70, 1077–1088 (2002).
Carlson, C. et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet. 61, 620–629 (1997).
Garcia-Miñaur, S. et al. A novel atypical 22q11.2 distal deletion in father and son. J Med Genet 39, E62 (2002).
Tan, T. Y. et al. Phenotypic variability of distal 22q11.2 copy number abnormalities. Am J Med Genet A 155A, 1623–1633 (2011).
Verhagen, J. M. A. et al. Phenotypic variability of atypical 22q11.2 deletions not including TBX1. Am J Med Genet A 158A, 2412–2420 (2012).
Guo, X., Freyer, L., Morrow, B. & Zheng, D. Characterization of the past and current duplication activities in the human 22q11.2 region. BMC Genomics 12, 71 (2011).
Baumer, A. High level of unequal meiotic crossovers at the origin of the 22q11. 2 and 7q11.23 deletions. Hum Mol Genet 7, 887–894 (1998).
Torres-Juan, L., Rosell, J., Sánchez-de-la-Torre, M., Fibla, J. & Heine-Suñer, D. Analysis of meiotic recombination in 22q11.2, a region that frequently undergoes deletions and duplications. BMC Med. Genet. 8, 14 (2007).
Gebhardt, G. S. et al. No evidence for a parental inversion polymorphism predisposing to rearrangements at 22q11.2 in the DiGeorge/Velocardiofacial syndrome. Eur. J. Hum. Genet. 11, 109–111 (2003).
Saitta, S. C. et al. Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion. Hum. Mol. Genet. 13, 417–428 (2004).
Alemany-Schmidt, A. et al. Geographical genetic variability: a factor to consider when assessing clinical implications of PRDM9. Mol. Genet. genomic Med. 2, 201–203 (2014).
Laurie, M. T. et al. Simultaneous digital quantification and fluorescence-based size characterization of massively parallel sequencing libraries. Biotechniques 55, 61–67 (2013).
Alkan, C. et al. Personalized copy number and segmental duplication maps using next-generation sequencing. Nat. Genet. 41, 1061–1067 (2009).
Boettger, L. M., Handsaker, R. E., Zody, M. C. & McCarroll, S. a. Structural haplotypes and recent evolution of the human 17q21.31 region. Nat. Genet. 44, 881–885 (2012).
Molina, O., Blanco, J., Anton, E., Vidal, F. & Volpi, E. High-resolution fish on DNA fibers for low-copy repeats genome architecture studies. Genomics 100, 380–386 (2012).
Nuttle, X., Itsara, A., Shendure, J. & Eichler, E. E. Resolving genomic disorder-associated breakpoints within segmental DNA duplications using massively parallel sequencing. Nat. Protoc. 9, 1496–1513 (2014).
Heng, H. H. Q., Windle, B. & Tsui, L.-C. High-Resolution FISH Analysis in Current Protocols in Human Genetics Supplement 44, Unit 4.5 (John Wiley & Sons, Inc., 2005).
Aten, E. et al. Methods to detect CNVs in the human genome. Cytogenet. Genome Res. 123, 313–321 (2008).
Redon, R. et al. Global variation in copy number in the human genome. Nature 444, 444–454 (2006).
Bittel, D. C. et al. Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogenet. Genome Res. 124, 113–120 (2009).
Peng, Z. et al. Correlation between frequency of non-allelic homologous recombination and homology properties: evidence from homology-mediated CNV mutations in the human genome. Hum. Mol. Genet. 24, 1225–1233 (2014).
Fusco, F. et al. Microdeletion/duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/IKKgamma exon4_10 deletion in families with incontinentia pigmenti. Hum. Mutat. 30, 1284–1291 (2009).
Jefferson, A. & Volpi, E. V. Fluorescence in situ hybridization (FISH) for genomic investigations in rat. Methods Mol. Biol. 659, 409–426 (2010).
Hussin, J. et al. Rare allelic forms of PRDM9 associated with childhood leukemogenesis. Genome Res. 23, 419–430 (2013).
This work was supported by project CF-180034 (Universitat Autònoma de Barcelona) and project 2014/SGR00524 (Agència de Gestió d’Ajuts Universitaris i de Recerca. Generalitat de Catalunya). Laia Vergés is recipient of a grant from the Universitat Autònoma de Barcelona (PIF/2012).
The authors declare no competing financial interests.
About this article
Cite this article
Vergés, L., Vidal, F., Geán, E. et al. An exploratory study of predisposing genetic factors for DiGeorge/velocardiofacial syndrome. Sci Rep 7, 40031 (2017). https://doi.org/10.1038/srep40031
This article is cited by
Nature Reviews Genetics (2020)